Literature DB >> 30715087

Pharmaceutical Company Payments to Executive Board Members of Professional Medical Associations in Japan.

Hiroaki Saito1, Akihiko Ozaki2, Yasuma Kobayashi3, Toyoaki Sawano4, Tetsuya Tanimoto2,5.   

Abstract

Mesh：

Year:  2019        PMID： 30715087      PMCID： PMC6450293          DOI： 10.1001/jamainternmed.2018.7283

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  3 in total

1.  Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.

Authors:  David J Rothman; Walter J McDonald; Carol D Berkowitz; Susan C Chimonas; Catherine D DeAngelis; Ralph W Hale; Steven E Nissen; June E Osborn; James H Scully; Gerald E Thomson; David Wofsy
Journal:  JAMA       Date:  2009-04-01       Impact factor: 56.272

2.  Types and Distribution of Payments From Industry to Physicians in 2015.

Authors:  Kathryn R Tringale; Deborah Marshall; Tim K Mackey; Michael Connor; James D Murphy; Jona A Hattangadi-Gluth
Journal:  JAMA       Date:  2017-05-02       Impact factor: 56.272

3.  Conflict of interest between professional medical societies and industry: a cross-sectional study of Italian medical societies' websites.

Authors:  Alice Fabbri; Giorgia Gregoraci; Dario Tedesco; Filippo Ferretti; Francesco Gilardi; Diego Iemmi; Cosima Lisi; Angelo Lorusso; Francesca Natali; Edit Shahi; Alessandro Rinaldi
Journal:  BMJ Open       Date:  2016-06-01       Impact factor: 2.692
  3 in total
  8 in total

1.  Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019.

Authors:  Anju Murayama; Sae Kamamoto; Hiroaki Saito; Kohki Yamada; Divya Bhandari; Iori Shoji; Hanano Mamada; Moe Kawashima; Erika Yamashita; Eiji Kusumi; Toyoaki Sawano; Binaya Sapkota; Tetsuya Tanimoto; Akihiko Ozaki
Journal:  Int J Environ Res Public Health       Date:  2022-06-16       Impact factor: 4.614

2.  Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan.

Authors:  Kana Yamamoto; Anju Murayama; Akihiko Ozaki; Hiroaki Saito; Toyoaki Sawano; Tetsuya Tanimoto
Journal:  Int Urogynecol J       Date:  2020-11-05       Impact factor: 2.894

3.  Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.

Authors:  Hiroaki Saito; Akihiko Ozaki; Toyoaki Sawano; Yuki Shimada; Tetsuya Tanimoto
Journal:  JAMA Netw Open       Date:  2019-04-05

4.  The Impact of Synchronous Telehealth Services With a Digital Platform on Day-by-Day Home Blood Pressure Variability in Patients with Cardiovascular Diseases: Retrospective Cohort Study.

Authors:  Ying-Hsien Chen; Chi-Sheng Hung; Ching-Chang Huang; Jen-Kuang Lee; Jiun-Yu Yu; Yi-Lwun Ho
Journal:  J Med Internet Res       Date:  2022-01-10       Impact factor: 5.428

5.  Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis.

Authors:  Akihiko Ozaki; Hiroaki Saito; Yosuke Onoue; Toyoaki Sawano; Yuki Shimada; Yurie Somekawa; Aritsune Tsuji; Tetsuya Tanimoto
Journal:  BMJ Open       Date:  2019-09-06       Impact factor: 2.692

6.  Financial ties between leaders of influential US professional medical associations and industry: cross sectional study.

Authors:  Ray Moynihan; Loai Albarqouni; Conrad Nangla; Adam G Dunn; Joel Lexchin; Lisa Bero
Journal:  BMJ       Date:  2020-05-27

7.  Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?

Authors:  Yurie Kobashi; Makoto Watanabe; Hideaki Kimura; Asaka Higuchi; Akihiko Ozaki
Journal:  Int J Health Policy Manag       Date:  2019-10-01

8.  Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians.

Authors:  Anju Murayama; Yuki Senoo; Kayo Harada; Yasuhiro Kotera; Hiroaki Saito; Toyoaki Sawano; Yosuke Suzuki; Tetsuya Tanimoto; Akihiko Ozaki
Journal:  Int J Environ Res Public Health       Date:  2022-03-15       Impact factor: 3.390
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.